All posts by: Michael Zand

The emerging role of immunotherapy in advanced urothelial cancers. – UroToday

The emerging role of immunotherapy in advanced urothelial cancers.UroTodayRecent Food and Drug Administration (FDA) approval of five new immune checkpoint inhibitors for the treatment of metastatic urothelial cancer represents the first major treatment… Continue reading

Immunotherapy combination increases overall survival in people with kidney cancer, study shows – News-Medical.net

News-Medical.netImmunotherapy combination increases overall survival in people with kidney cancer, study showsNews-Medical.netTreating people with advanced metastatic kidney cancer using a combination of the immunotherapy drugs nivolumab (Opdivo®) and … Continue reading

Joyn Bio formed to bring synthetic biology to agriculture | Wallaces … – Wallace’s Farmer

Joyn Bio formed to bring synthetic biology to agriculture – Farm Futures

ArQule (NASDAQ:ARQL) and Editas Medicine (EDIT) Financial Contrast – The Ledger Gazette

ArQule (NASDAQ:ARQL) and Editas Medicine (EDIT) Financial ContrastThe Ledger GazetteIt is developing a genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR) technology. CRISPR uses a protein-ribonucleic ac… Continue reading

CRISPR tech brews hopless beer with hoppy taste – New Atlas

New AtlasCRISPR tech brews hopless beer with hoppy tasteNew AtlasBiologists at the University of California, Berkeley have used CRISPR technology to create a hop-free brew that still has all the flavor and aroma of conventional beer. By replacing the h… Continue reading